DERMA PHARM A/S: Financial statements 2012
CVR: 89453119
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 19,403,901 and a net result of DKK 1,071,636. Equity in the 2012 report amounted to DKK 15,684,751. The solvency ratio was 25.8%.
- Gross Profit
- DKK 19,403,901
- Profit/Loss
- DKK 1,071,636
- Equity
- DKK 15,684,751
- Total Assets
- DKK 60,910,578
Official annual report
Keep an eye on DERMA PHARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of January 2, 2012, Statsautoriseret revisor Søren Cortsen has been appointed auditor of DERMA PHARM A/S.
As of January 2, 2012, RÅDGIVNINGSGRUPPEN ApS has stepped down as auditor of DERMA PHARM A/S.
As of January 2, 2012, SC STATSAUTORISERET REVISIONSANPARTSSELSKAB has stepped down as auditor of DERMA PHARM A/S.
About DERMA PHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 120 employees (2018). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.